Krokodile Injectors in Ukraine: Fueling the HIV Epidemic?

AIDS and Behavior

Volumn 20, Issue 2, 2016, Pages 369-376

  Booth, Robert E ^a,b   Davis, Jonathan M ^a   Brewster, John T ^a   Lisovska, Oksana ^c   Dvoryak, Sergey ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UKRAINIAN INSTITUTE ON PUBLIC HEALTH POLICY   (Ukraine)

Author keywords

Krokodile; People who inject drugs; Ukraine

Indexed keywords

CODEINE; KROKODIL; STREET DRUG;

ADULT; ANALOGS AND DERIVATIVES; CITY; COMPLICATION; EPIDEMIC; FEMALE; HIGH RISK BEHAVIOR; HIV INFECTIONS; HUMAN; INCIDENCE; INJECTION; MALE; RISK REDUCTION; SUBSTANCE ABUSE; UKRAINE;

ADULT; CITIES; CODEINE; EPIDEMICS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INJECTIONS; MALE; RISK REDUCTION BEHAVIOR; RISK-TAKING; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; UKRAINE;

EID: 84958178733     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-015-1008-z     Document Type: Article

References (43)

1. WHO (World Health Organization). The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec. 1995;50:355–7.
2. Khodakevich L, Dehne K. HIV epidemics in drug using populations and increasing drug use in central and Eastern Europe. Geneva; 1998.
3. Ukraine: Ministry of Health. HIV Infection in Ukraine. Kiev; 2007.
4. Joint United Nations Programme on HIV/AIDS. Ukraine: progress towards universal access [Internet]. http://www.unaids.org/en/CountryResponses/Countries/ukraine.asp. Accessed 11 Feb 2010.
5. WHO/Europe Survey on HIV/AIDS and Antiretroviral Therapy. Sexually transmitted infections/HIV/AIDS. Geneva; 2007.
6. Ministry of Health Ukraine, Ukrainian AIDS Center, The LV Gromashevskyi Institute of Epidemiology and Infectious Diseases of AMS of Ukraine. HIV in Ukraine: information bulletin No. 37. 2011.
7. Ministry of Health Ukraine, Ukrainian AIDS Center, WHO, International HIV/AIDS Alliance in Ukraine. Report on the national consensus estimates on HIV and AIDS in Ukraine as of the end of 2005. 2006.
8. Barnett T, Whiteside A, Khodakevich L, Kruglov Y, Steshenko V. The HIV/AIDS epidemic in Ukraine: its potential social and economic impact. Soc Sci Med. 1982;2000(51):1387–403.
9. Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323–36.
10. Dehne KL, Pokrovskiy V, Kobyshcha Y, Schwartländer B. Update on the epidemics of HIV and other sexually transmitted infections in the newly independent states of the former Soviet Union. AIDS Lond Engl. 2000;14(Suppl 3):S75–84.
11. Rhodes T, Sarang A, Bobrik A, Bobkov E, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy. 2004;15:1–16.
12. Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Semerik O. Predictors of self-reported HIV infection among drug injectors in Ukraine. J Acquir Immune Defic Syndr. 1999;2004(35):82–8.
13. Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS Lond Engl. 2006;20:2217–23.
14. Dehne K, Grund J, Khodakevich L, Kobyshcha Y. The HIV/AIDS epidemic among drug injectors in Eastern Europe: patterns, trends and determinants. J Drug Issues. 1999;29:729–76.
15. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep. 1998;113:170–81.
16. Chintalova-Dallas R, Case P, Kitsenko N, Lazzarini Z. Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. Int J Drug Policy. 2009;20:347–51.
17. Small L, Yuen K, Eilers L. The catalytic hydrogenation of the halogenomphides: dihydrodesoxymorphine-D1. J Am Chem Soc. 1933;55:3863–70.
18. Small LF. Morphine derivatives and processes. US Patient 1980972; 1934.
19. Eddy N, Howes H. Studies of morphine, codeine and their derivatives x. desoxymorphine-c, despoxycodeine-c and their hydrogenated derivatives. J Pharm Exp Ther. 1935;55:257–67.
20. Janssen PA. A review of the chemical features associated with strong morphine-like activity. Br J Anaesth. 1962;34:260–8.
21. Sargent LJ, May EL. Agonists-antagonists derived from desomorphine and metopon. J Med Chem. 1970;13:1061–3.
22. Weill P, Weiss U. The structure of morphine. Chemistry of the totally or partially synthetic analgesics. UN Bull Narc. 1951;2:12–31.
23. Skowronek R, Celiński R, Chowaniec C. “Crocodile”—new dangerous designer drug of abuse from the East. Clin Toxicol Phila PA. 2012;50:269.
24. Gahr M, Freudenmann RW, Hiemke C, Gunst IM, Connemann BJ, Schönfeldt-Lecuona C. Desomorphine goes “crocodile”. J Addict Dis. 2012;31:407–12.
25. Harris M. The, “do-it-yourself” New Zealand injecting scene: implications for harm reduction. Int J Drug Policy. 2013;24:281–3.
26. Walker S. Krokodil: The drug that eats junkies [Internet]. The Independent. http://www.independent.co.uk/news/world/europe/krokodil-the-drug-that-eats-junkies-2300787.html. Accessed 28 Apr 2014.
27. Shuster S. The curse of the crocodile: Russia’s deadly designer drug. 2013. http://www.time.com/world/article/0,8599,2078355,00.html. 1 Nov 2013.
28. Grund J-PC, Latypov A, Harris M. Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia. Int J Drug Policy. 2013;24:265–74.
29. Carlson R, Wang J, Siegal H, Falck R, Guo J. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ. 1994;53:279–86.
30. Wiebel W. Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. In: Battjes RJ, Pick. RW, editors. Needle Shar. Intraven. Drug Users Natl. Int. Perspect. Washington, D.C: US Printing Office; 1998. p. 137–50.
31. Dowling-Guyer S, Others A. Reliability of drug users’ self-reported hiv risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1:383–92.
32. Weatherby N, Needle R, Cesar H, Booth R, McCoy C, Watters J, et al. Validity of self-reported drug use among injection drug users and crack smokers recruited through street outreach. Eval Program Plan. 1994;17:347–55.
33. Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa, Ukraine. J Psychoact Drugs. 2003;35:419–26.
34. Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1974;1998(113 Suppl 1):151–9.
35. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22:332–9.
36. Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 1982;2009(68):740–8.
37. Coyle SL. The NIDA HIV Counseling and Education Intervention Manual. Rockville, MD: National Institute on Drug Abuse; 1993.
38. Fordyce EJ, Blum S, Shum R, Singh TP, Chiasson MA, Thomas P. The changing AIDS epidemic in New York City: a descriptive birth cohort analysis of AIDS incidence and age at diagnosis. AIDS Lond. Engl. 1995;9:605–10.
39. Macalino G, Nelson K, Vlahov D, Celentano D, Safaeian M, Strathdee S. Temporal trends, demographic and behavioral risk factors for HIV seroconversion among Baltimore drug users, 1988-1997. Acapulco; 1999.
40. Wenston J, DesJarlais D, Sotheran J, Friedman S, Marmor M. Racial differences in the impact of HIV seroprevalence among active injectors in New York City. Atlanta; 1991.
41. Booth RE, Lehman WE, Brewster JT, Sinitsyna L, Dvoryak S. Gender differences in sex risk behaviors among Ukraine injection drug users. J Acquir Immune Defic Syndr. 1999;2007(46):112–7.
42. Maisto S, McKay J, Conners G. Self-reported issues in substance abuse: state of the art and future directions. Behav Assess. 1990;121:117–34.
43. Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996;42:11–20.